Company No: 04210685 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

DIRECTORS	Alfred David Allen
	Richard Oliver Allen

REGISTERED OFFICE	Treviot House
	186-192 High Road
	Ilford
	IG1 1LR
	United Kingdom

COMPANY NUMBER

04210685 (England and Wales)

ACCOUNTANT	Gravita Essex Limited
	Treviot House
	186-192 High Road
	Ilford
	Essex
	IG1 1LR
	United Kingdom

	Note	2025		2024
		£		£
Fixed assets
Tangible assets	3	5,954		5,657
Investments	4	100		100
		6,054		5,757
Current assets
Stocks	5	70,302		34,993
Debtors	6	281,613		699,468
Cash at bank and in hand	7	1,992,556		1,245,590
		2,344,471		1,980,051
Creditors: amounts falling due within one year	8	( 1,017,054)		( 649,902)
Net current assets		1,327,417		1,330,149
Total assets less current liabilities		1,333,471		1,335,906
Net assets		1,333,471		1,335,906
Capital and reserves
Called-up share capital		201		201
Profit and loss account		1,333,270		1,335,705
Total shareholders' funds		1,333,471		1,335,906

For the financial year ending 30 June 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Income Statement has not been delivered.

The financial statements of ADAllen Pharma Limited (registered number: 04210685) were approved and authorised for issue by the Board of Directors on 20 October 2025. They were signed on its behalf by:

Richard Oliver Allen Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

ADAllen Pharma Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Treviot House, 186-192 High Road, Ilford, IG1 1LR, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Income Statement in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill

Goodwill arises on business combination and represents any excess of consideration given over the fair value of the identifiable assets and liabilities acquired. Goodwill is initially recognised as an intangible asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight line basis over its useful economic life, which is 10 years.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery	25 % reducing balance
Fixtures and fittings	25 % reducing balance
Computer equipment	33 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	13		10

3. Tangible assets

	Plant and machinery		Fixtures and fittings		Computer equipment		Total
	£		£		£		£
Cost
At 01 July 2024	73,500		79,324		73,025		225,849
Additions	0		1,950		2,916		4,866
	0		0		0		0
At 30 June 2025	73,500		81,274		75,941		230,715
Accumulated depreciation
At 01 July 2024	73,500		77,850		68,842		220,192
Charge for the financial year	0		1,266		3,303		4,569
	0		0		0		0
At 30 June 2025	73,500		79,116		72,145		224,761
Net book value
At 30 June 2025	0		2,158		3,796		5,954
At 30 June 2024	0		1,474		4,183		5,657

4. Fixed asset investments

Investments in subsidiaries

	2025
	£
Cost
At 01 July 2024	100
At 30 June 2025	100
Carrying value at 30 June 2025	100
Carrying value at 30 June 2024	100

5. Stocks

	2025		2024
	£		£
Stocks	70,302		34,993

6. Debtors

	2025		2024
	£		£
Trade debtors	196,932		636,281
Amounts owed by Group undertakings	72,311		45,195
Other debtors	12,370		17,992
	281,613		699,468

7. Cash and cash equivalents

	2025		2024
	£		£
Cash at bank and in hand	1,992,556		1,245,590

8. Creditors: amounts falling due within one year

	2025		2024
	£		£
Trade creditors	610,956		229,776
Taxation and social security	82,719		138,518
Other creditors	323,379		281,608
	1,017,054		649,902

SECURED DEBTS
Lloyds bank commercial finance limited has a fixed and floating charge against all the business assets.